Abstract

A wide variety of conditions can present as acute polyarthritis, ranging from those that are potentially life threatening, to those that are self-limiting, and those that represent the early stages of a persistent and potentially destructive form of arthritis. In this article, we describe the diagnostic approach and initial management of patients with recent onset polyarthritis, with the aid of an illustrative case vignette.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61(4):290-7.
2. Suresh E. Diagnosis of early rheumatoid arthritis: what the nonspecialist needs to know. J R Soc Med 2004;97(9):421-4.
3. Fransilla R, Hedman K. Infection and musculoskeletal conditions: viral causes of arthritis. Best Pract Res Clin Rheumatol 2006;20:1139- 57.
4. Toivanen A, Toivanen P. Which viruses should we look for in a recent onset polyarthritis. Acta Rheumatol Port 2006;31(1):39-47.
5. Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000; 12(4): 289-94.
6. Lui NL, Leong HN, Thumboo J. Polyarthritis in four patients with Chikungunya arthritis. Singapore Med J 2012;53(4):241-3.
7. Christodoulou C, Gordon P, Coakley G. Polyarticular septic arthritis. BMJ 2006;333(75):1107-8.
8. Dubost JJ, Fis I, Denis P, et al. Polyarticular septic arthritis. Medicine 1993;72(5):296-310.
9. Kwiatkowska B, Filipowicz-Sosnowska A. Reactive arthritis. Pol Arch Med Wewn 2009;119(1-2):60-5.
10. Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 2004;43:949-954.
11. Kroot EJ, Hazes JM, Colin EM, Dolhain RJ. Poncet’s disease: reactive arthritis accompanying tuberculosis. Two case reports and a review of the literature. Rheumatology (Oxford) 2007;46(3):484-9.
12. Holden W, Orchard T, Wordsworth P. Enteropathic arthritis. Rheum Dis Clin North Am 2003;29(3):513-30.
13. Suresh E. Diagnosis and management of gout: a rational approach. Postgrad Med J 2005;81(959):572-9.
14. Hadler NM, Franck WA, Bress NM, Robinson DR. Acute polyarticular gout. Am J Med 1974;56(5):715-9.
15. Lawry GV 2nd, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine (Baltimore) 1988;67(5):335-43.
16. Ravi Kumar AS, Bui C, Szwarc G, Dixson H. Florid polyarticular gout mimicking septic arthritis. Clin Nucl Med 2004;29:262-3.
17. Banks SE. Erosive osteoarthritis: a current review of a clinical challenge. Clin Rheumatol 2010;29(7):697-706.
18. Hart FD. Drug-induced arthritis and arthralgia. Drugs 1984;28(4):347-54.
19. Puius YA, Kalish RA. Lyme arthritis: pathogenesis, clinical presentation, and management. Infect Dis Clin North Am 2008;22(2):289-300.
20. Wolfe F, Ross K, Hawley DJ, et al. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 1993;20(12):2005-9.
21. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004;50(3):709-15.
22. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46(2):357-65.
23. Green M, Marzo-Ortega H, McGonagle D, et al. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum 1999;42(10):2184-8.
24. McQueen FM, Stewart N, Crabbe J, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at 4 months after symptom onset. Ann Rheum Dis 1998;57:350-56.
25. Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Longterm impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006;55(6):864-72.
26. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43(1):22-9.
27. Wiles NJ, Lunt M, Barrett EM, et al. Reduced disability at 5 years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Arthritis Rheum 2001;44(5):1033-42.
28. Saraux A, Maillefert JF, Fautrel B, et al. Laboratory and imaging studies used by French rheumatologists to determine the cause of recent onset polyarthritis without extra-articular manifestations. Ann Rheum Dis 2002;61:626-9.
29. Zerrak A, Bour JB, Tavernier C, et al. Usefulness of routine hepatitis C virus, hepatitis B virus, and parvovirus B19 serology in the diagnosis of recent-onset inflammatory arthritides. Arthritis Rheum 2005; 53(3):477-8.
30. Varache S, Narbonne V, Jousse-Joulin S, et al. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study. Arthritis Care Res (Hoboken) 2011;63(11):1565-70.
31. Mottonen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
32. Emery P. The Dunlop-Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. J Rheumatol 1997;24(7):1436-42.
33. Suresh E. Systemic lupus erythematosus: diagnosis for the nonspecialist. Br J Hosp Med 2007;68(10):538-41.
34. Farid SSh, Azizi G, Mirshafiey A. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis. Int J Rheum Dis 2013;16(4):379-86.
35. van Gaalen FA, Lin-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004;50(3):709-15.
36. Ostergaard M, Ejbjerg B, Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol 2005;19(1):91-116.
37. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34- 45.
38. Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 2013;15 Suppl 3:S2.
39. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115(12):1634-42.
40. Lanas A, Boers M, Nuevo J. Gastrointestinal events in atrisk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice. Ann Rheum Dis 2013 Dec 18 [Epub ahead of print].
41. Gorter SL, Bijlsma JW, Cutolo M, et al. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2010;69(6):1010-4.
42. Suresh E. Management of early rheumatoid arthritis. J Assoc Physicians India 2007;55:355-62.
43. van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862-73.
44. Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology (Oxford) 2005;44(12):1473-82.